Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 5/20 | 0.58 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.58 |
| ▸ | SLC6A12 | P48065 | 3/20 | 0.54 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.54 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL377179 | 1.00 | GABRR1 (0.58) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL25660412 | 1.00 | GABRR1 (0.58) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL16249750 | 0.90 | SLC6A12 (0.54) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL1260796 | 0.81 | SLC6A12 (0.46) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL14963184 | 0.80 | GABRR1 (0.54) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL26951501 | 0.80 | SLC6A12 (0.50) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL26951525 | 0.80 | SLC6A12 (0.50) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL28961634 | 0.77 | SLC6A12 (0.65) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL11521796 | 0.77 | SLC6A12 (0.65) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 | |
| SCHEMBL7813782 | 0.77 | SLC6A12 (0.65) | GABRR1GABRR2SLC6A12SLC6A11SLC6A13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | PAICS, LNPEP, DNPEP | GABRR1 2224/4885GABRR2 2350/4885SLC6A12 1586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.